期刊文献+

VanC型肠球菌与屎肠球菌对常用抗菌药的耐药状况研究 被引量:5

Study on the resistance rate of Van C type Enterococcus and Enterococcus faecium to antibiotics
原文传递
导出
摘要 目的比较Van C型肠球菌及屎肠球菌对常用抗菌药物的敏感性。方法针对56株Van C型肠球菌及299株屎肠球菌,用琼脂二倍稀释法进行药物敏感性分析;检测高水平耐万古霉素屎肠球菌的万古霉素耐药基因型。结果Van C型肠球菌万古霉素最低抑菌浓度(MIC)众数为4 mg·L-1,未发现对氨苄西林、万古霉素、替考拉宁及利奈唑胺耐药的Van C型肠球菌。屎肠球菌对氨苄西林、左氧氟沙星、红霉素及利福平的耐药率均达85%以上;对万古霉素和替考拉宁的耐药率分别为1.7%和0.7%;未发现对利奈唑胺和替加环素耐药的屎肠球菌。屎肠球菌万古霉素MIC众数为0.5 mg·L-1。5株万古霉素屎肠球菌万古霉素耐药基因均为van A型。结论屎肠球菌对万古霉素尚保持较高敏感性,万古霉素对Van C型肠球菌最低抑菌浓度较屎肠球菌高。 Objective To compare susceptibility of the VanC phenotype Enterococcus and Enterococcus faecium to antibiotics normally used in clinical.Method The antimicrobial susceptibility of 53 isolates of VanC type Enterococcus and 299 isolates of E.faecium were determined by argar dilution.The vancomycin resistance genes were analysis of high-level vancomycin- resistant E.faecium.Results The median minimum inhibitory concentration( MIC) distribution of VanC phenotype Enterococcus to wancomycin was 4 mg · L^-1,no VanC phenotype Enterococcus were found resistant to ampicilin,vancomycin,teicoplanin and linizolid.The resistant rates of E.faecium to ampicillin,levofloxacin,erythromycin and rifampin were above 85%.The resistant rates of E.faecium to vancomycin and teicoplanin were 1.7% and 0.7%,sepreately.No E.faecium isolates were found resistant to linizolid.The median MIC distribution of E.faecium to vancomycin was 0.5 mg·L^-1.van A gene were found in 5 isolates of vancomycin resistant E.faeciums.Conclusion E.faecium remained sensitive to vancomycin,the MIC of vancomycin to VanC phenotype Enterococcus were higher than that of E.faecium.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第1期14-16,24,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金面上基金资助项目(81171612) 国家科技支撑计划基金资助项目(2012EP001000)
关键词 VanC型肠球菌 屎肠球菌 万古霉素 耐药 VanC type Enterococcus Enterococcus faecium vancomycin resistant drugs
  • 相关文献

参考文献3

二级参考文献24

  • 1李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:224
  • 2李爽,张正.对万古霉素耐药的11株肠球菌的药敏表型及基因检测[J].中华检验医学杂志,2005,28(4):426-429. 被引量:17
  • 3Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Wayne: Clincial and Laboratory Standards Institute, 2009.
  • 4Zhu X, Zheng B, Wang S, et aL Molecular characterization of outbreak - related strains of vancomycin - resistant Enterococcus faecium from an intensive care unit in Beijing, Chin[J]. J Hosp lnfec, 2009; 72 : 147 - 154.
  • 5Klare I, Konsabel C, Badstubner D, et al. Occurrence and spread of antibiotic resistances in Enterococcus faecium[ J]. Int J Food Microbiol, 2003 ;88 : 269 - 290.
  • 6Chow JW, Kak V. Acquired antibiotic resistances in Eaterococci[ A].Gilmore MS. The Enterococci : Pathogenesis, Molecular Biology, and Antibiotic Resistance [ M ].Washington DC : ASM Press, 2002 : 355 -384.
  • 7National Nosocomial Infections Surveillance (NNIS) System Report.Data summary from January 1992 through June 2004 [ J/OL ]. http ://www. cdc. gov/ncidod/dhqp/pdt/nnis/2004NNISreport.pdf,2004-10-01.
  • 8Ike Y, Tanimoto K, Tomita H, et al. Efficient transfer of the pheromone- independent Enterococcus faecium plsmid pMG1 (Gmr) (65.1 kilobases) to Enterococcus strains during broth mating[ J]. J Bacteriol,1998; 180:4884 -4892.
  • 9Florence D, Perichon B, Courvalin P. Detection of the van alphabet and identification of Enterococci and staphylococci at the species level by multiplex PCR [ J ]. J Clin Microbiol, 2004 ;42 : 5857 - 5860.
  • 10Dutka - Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant Enterococci by PCR [ J ]. J Clin Microbiol, 2004 ; 33:24 - 27.

共引文献177

同被引文献69

  • 1王艳宁,钟慧.头孢哌酮舒巴坦钠致凝血功能障碍临床分析[J].中国药物应用与监测,2005,2(5):54-55. 被引量:26
  • 2皮博睿,俞云松.万古霉素不敏感革兰阳性菌感染研究进展[J].中国处方药,2006(9):10-13. 被引量:8
  • 3卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 4陈新谦,金有豫,汤光.新编药物学:第17版[M].北京:人民出版社,2011:96-97..
  • 5Liu B, Liu Y, Di X, et al. Colistin and anti-Gram-positive bacte- rial agents against acinetobacter baumannii[ J]. Rev Soc Bras Med Trop, 2014,47(4) :451-456.
  • 6Wang B, Chai W, Ding G. The application of functional silica nanoparticles to fulfill the rapid and improved enantioselectivc cap- illary electrophoresis separation of amino acid derivatives[ J]. J Sep Sci, 2015,38(2) :332-338.
  • 7Soliman SM. Validated densitometrie TLC-method for the simulta- neous analysis of (R)- and (S)-citalopram and its related substances using macrocyclic antibiotic as a chiral selector: application to the determination of enantiomeric purity of escitalo- pram[J]. Int J Biomed Sei, 2012,8( 1 ) :40-50.
  • 8Fei J, Liu GD, Pan C J, el al. Preparation, release profiles and antibacterial properties of vancomycin-loaded Ca-P coating titanium alloy plate[J]. J Mater Sci Mater Med, 2011,22(4) :989-995.
  • 9上海市卫生局.关于印发《上海市抗菌药物临床应用分级管理目录(2012年版)》的通知[z].沪卫医政[2012]081号.
  • 10Teng LD, Xin HW, Blix HS, et al. Review of the use of defined daily dose concept in drug utilization research in China [ J ]. Pharmacoepidemiol Drug Saf, 2012 (21 ) : 1118.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部